CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- 4 Grant or award Chief Medical Officer acquired 11,250 shares (grant or award)
- 4 Grant or award CFO acquired 11,250 shares (grant or award)
- 4 Grant or award Chief Legal & Business Officer acquired 13,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP-CSO Microbiome sold 1,297 shares at $6.15 ($7,983)
- 4 Open-market sale Chief Medical Officer sold 4,397 shares at $5.10 ($22,404)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO and President sold 12,151 shares at an average $21.80 ($264,917)
- 4 Gift Director gave 2,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CSO, Virology acquired 45,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP-CSO Microbiome sold 1,254 shares at $14.22 ($17,831)
- 4 Open-market sale EVP & CSO, Virology Ops sold 7,812 shares at $15.04 ($117,524)
Page 8 of 17 · 337 filings